Cure SMA Foundation of India is a registered public charitable trust with representation across India. From a humble beginning of ten families, we have grown to represent SMA families and individuals across the country.

Each year we support families through counselling for the newly diagnosed, a shared resource pool, SMA clinics, patient advocacy, and many other direct services. We work to empower people with SMA to access the services and facilities that already exist — and to bring life-saving SMA therapies to India.

Cure SMA India played an important role in the launch of Risdiplam, an oral SMA treatment, in India. Today we work with all stakeholders to make treatment accessible to every person with SMA. We are dedicated to our members, to the Indian SMA community, and to a future of universal access to SMA therapies.

Members of Cure SMA India at a felicitation on Women's Day

Mission and vision

Our mission

To bring treatment and a cure for SMA to India; to make healthcare accessible, inclusive, and insured for all; and to raise awareness of SMA and the importance of genetic screening, so that we can build a world without genetic disease.

Our vision

An SMA-free world, and barrier-free universal healthcare for all.

Our values

What guides every decision we make

Integrity

We carry out all our work with the greatest responsibility and accountability.

Balance

We pursue treatment and a cure relentlessly but strategically, balancing optimism with realism.

Collaboration

Researchers, doctors, and families together are — and always will be — stronger than SMA.

Respect

Every person with SMA has the right to a dignified life, lived the way they choose.

Compassion

No one is alone in this fight. We offer unconditional support and clear, honest information.

Determination

We will stay strong in our fight for a world free of genetic disease, whatever challenges come.

There is no right way to live with a disease like SMA. Every person’s experience is different, and it is every family’s right to decide what SMA means to them.
Our journey

Milestones

Phase I · 2014–2017

Connecting families, creating hope

  1. 2014

    The journey begins

    • Founded by a small group of parents of children with Spinal Muscular Atrophy.
    • Established India’s first national parent support network for SMA families.
    • Began raising awareness among families and healthcare professionals.
  2. 2015

    Building the community

    • Started the first national SMA patient registry.
    • Expanded family support and counselling.
  3. 2016

    Advocacy begins

    • Strengthened national advocacy for better diagnosis, standards of care, and access to treatment.
  4. 2017

    Introducing multidisciplinary care

    • Established India’s first SMArt Multidisciplinary Clinic at Peerless Hospital, Kolkata.
    • Filed a Public Interest Litigation in the Delhi High Court seeking treatment access for SMA families.
    • Intensified advocacy for a national Rare Disease Policy, including a meeting with Union Health Minister J. P. Nadda.
    • Took part in the first World Congress on Accessibility to Medical Products, organised by the WHO and the Ministry of Health & Family Welfare.
Phase II · 2018–2020

From community to national voice

  1. 2018

    Formally registered

    • Registered as a pan-India not-for-profit organisation.
    • Expanded engagement with government regulators, clinicians, and pharmaceutical companies.
  2. 2019

    Expanding access and national presence

    • Organised the 1st National Conference on SMA with Peerless Hospital, Kolkata.
    • Brought together the Ministry of Health & Family Welfare and Direct Relief — 21 Indian children received Spinraza through the humanitarian programme (SIPHAP).
    • Supported the approval of Roche’s compassionate-use programme for Risdiplam in India.
    • Expanded SMArt Multidisciplinary Clinics to PGIMER, Chandigarh.
    • Advocated with IRDAI for insurance cover for genetic and rare diseases, and obtained 12A and 80G certification.
  3. 2020

    Policy reform during the pandemic

    • Advocacy contributed to amendments to the New Drugs and Clinical Trials Rules, 2019, easing access to therapies for rare diseases.
    • Established the National SMA Task Force of multidisciplinary clinicians and published Standards of Care for SMA during COVID-19 and beyond.
    • Ran nationwide virtual awareness programmes, webinars, and stakeholder consultations.
Phase III · 2021–2023

Driving policy, access, and partnerships

  1. 2021

    Expanding treatment access

    • Risdiplam approved in India.
    • Expanded SMArt Multidisciplinary Clinics to SRCC Children’s Hospital (Mumbai), Rajasthan Hospital – RICN (Ahmedabad), and Sir Ganga Ram Hospital (New Delhi).
    • Began state-level advocacy for treatment access, and for customs-duty and GST exemption on rare-disease medicines.
  2. 2022

    A national policy milestone

    • Advocacy contributed to the exemption of customs duty on imported life-saving medicines for rare diseases in Union Budget 2022–23.
    • Expanded SMArt Multidisciplinary Clinics to Rainbow Children’s Hospital (Hyderabad) and SAT Hospital (Kerala).
  3. 2023

    Government treatment support and public awareness

    • Kerala became the first state government to support treatment for eligible children with SMA.
    • Filed a case in the Delhi High Court seeking structured negotiations between the Government of India and pharmaceutical companies for affordable treatment.
    • Launched Run for SMA, an awareness marathon in Hyderabad — held every year since.
Phase IV · 2024–2026

Building the future of rare disease care

  1. 2024

    Research, partnerships, and national outreach

    • Organised the 2nd National SMArtCon in Gurugram with the Tata Institute for Genetics and Society (TIGS).
    • Delhi High Court verdict in favour of patients’ access to treatment.
    • Began the first indigenous SMA research collaboration, with IIT Kanpur’s Department of Biological Sciences & Bioengineering.
    • Launched the multilingual SMA Knowledge Series and expanded the SMArt Multidisciplinary Clinic network.
    • Began work with the Integral Coach Factory, Chennai, and the Railway Board on accessibility in Vande Bharat trains.
    • Began a partnership with Microsoft India, with awareness events held every year since.
    • Syniti donated wheelchairs and other equipment for people with SMA.
    • Held the 2nd Run for SMA.
  2. 2025

    Innovation and accessibility

    • Organised the 3rd National SMArtCon in Thiruvananthapuram with the National Health Mission, Kerala.
    • Hosted the first SMA Research & Technology Summit with TIGS.
    • Soft-launched eSwayam, India’s Digital Accessibility Map — a community-driven platform for persons with disabilities.
    • Began awareness sessions with Google.
    • Syniti donated more wheelchairs and equipment.
    • Held the 3rd Run for SMA.
  3. 2026

    Growing partnerships

    • Held the 4th Run for SMA.
    • Expanded corporate engagement through new partnerships with Salesforce, Egen, and Shriram Life Sciences.